Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-77,041.51
% of Total Estimate Gain
-6.18%

Thrivent Mid Cap Growth Portfolio's Chemed Corp Holding Summary

As of 2024-12-31, THRIVENT SERIES FUND INC held - shares of Chemed Corp(CHE), totaling N/A. This investment constitutes 0% of their stock portfolio, and THRIVENT SERIES FUND INC now holds 0% of the outstanding Chemed Corp(CHE) stock.

The initial trade took place in 2024Q1. And since then Thrivent Mid Cap Growth Portfolio has made 3 purchases of CHE, at an average price of $600.35, for a total of 2,077.00 shares. In addition, there have been 1 sales at an average price of $563.26 for 2,077.00 shares. Based on historical transaction data and CHE's current price of $460.70, Thrivent Mid Cap Growth Portfolio's estimated gain on his CHE holdings is $-77,041.51, reflecting a -6.18% gain to date.

Thrivent Mid Cap Growth Portfolio CHE ($460.70) Holding Chart

Thrivent Mid Cap Growth Portfolio CHE ($460.70) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1